Jeito is a global biotech investment firm with a patient-benefit approach that funds and accelerates breakthrough medical innovations. The company focuses on supporting entrepreneurs in life sciences across Europe and the United States, empowering portfolio companies to advance therapeutics and improve patient outcomes. Based in Paris with a presence in Europe and the US, Jeito combines deep scientific expertise with capital to build market-leading biotech companies. The firm emphasizes impact on society by promoting access to breakthrough medicines worldwide.
No recent news for this company.